2Yuh YJ, Lee HR, Kim SR, et al. Gemcitabine and carboplatin combination chemotherapy for elderly patient with advanced non-small lung cancer: A feasibility study [J]. Cancer Res Treat, 2008, 40(3):116-120. 被引量：1
3Yu Y, Xu X, Du Z, et al. Non-platinum regimens of gemcitabine plus docetaxel versus platinum-based regimens in first-line treatment of advanced non-small cell lung cancer: a meta- analysis on 9 randomized controlled trials[J]. Cancer Chemother Pharmacol, 2012, 69(5): 1265-1275. 被引量：1
4Georgoulias V, Ardavanis A, Tsiafaki X, et al. Vinorelbine plus cisplatin versus docetaxel plus gemcitabine in advanced non- small-cell lung cancer: a phase Ⅲ randomized trial [J]. J Clin Oncol, 2005, 23(13):2940-2942. 被引量：1
5Baykara M, Coskun U, Berk V, et al. Gemcitabine plus paclitaxel as second-line chemotherapy in patient with advanced non-Small cell cancer[J]. Asian Pac J Cancer Prev, 2012, 13(10):5119- 5121. 被引量：1
6Jiang J, Liang X, Zhou X, et al. PacIitaxeI plus platinum or gemcitabine plus platinum in first-line treatment of advanced non-small-cell lung cancer: results from 6 randomized controlled trials[J]. IntJ Clin Oncol, 2012, Epub ahead of print. 被引量：1
7Minami S, Kijima T, Shiroyama T, et al. Randomized phase Ⅱ trial of paclitaxel and carboplatin followed by gemcitabine switch-maintenance therapy versus gemcitabine and carboplatin followed by gemcitabine continuation-maintenance therapy in previously untreated advanced non-small cell lung cancer[J]. BMC Res Notes, 2013, 6(1): 3. 被引量：1
8Lv C, based Ma Y, induc Wu N, et al. A retrospective study: platinum chemo or paclitaxel for stage therapy combined with gemcitabine Ⅱ B- ⅢA central non-small-cell lung cancer[J]. World J Surg Oncol, 2013, 11:76. 被引量：1
9Gridelli C, Aapro M, Ardizzoni A, et al. Treatment of advanced non-small-cell lung cancer in the elderly: results of an international expert panel [J]. J Clin Oncol, 2005, 23( 13): 3125-3137. 被引量：1
